Literature DB >> 12352880

Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells.

Toru Higuchi1, Andrés Jaramillo, Zahid Kaleem, G Alexander Patterson, T Mohanakumar.   

Abstract

BACKGROUND: Both T and B cells have been shown to be implicated in the pathogenesis of bronchiolitis obliterans syndrome, which is considered to represent chronic lung allograft rejection. However, the relative contributions of T cells and alloantibodies in the pathogenesis of the disease are still unknown. In this study, we used an heterotopic murine tracheal transplantation model to determine the contribution of these components of the immune system in the pathogenesis of posttransplant obliterative airway disease (OAD).
METHODS: Tracheal allografts from BALB/c and HLA-A2-transgenic (HLA-A2+) mice were heterotopically transplanted into C57BL/6, CD4-knockout (KO), CD8-KO, Ig-KO, and Rag1-KO mice. In additional experiments, recipient mice were pretreated with depleting antibodies against CD4+, CD8+, and NK1.1+ cells. Development of OAD was determined by histopathology at days 10, 30, 60, 90, and 180 after transplantation.
RESULTS: HLA-A2+ allografts transplanted into C57BL/6, CD8-KO, and Ig-KO mice demonstrated OAD lesions by day 30. In contrast, allografts transplanted into CD4-KO mice showed no OAD lesions at day 30, partial OAD development by days 60 and 90, and complete OAD development by day 180. No OAD development was observed in allografts transplanted into Rag1-KO mice. Treatment with anti-NK1.1 antibody did not show any effect on posttransplant OAD development. In contrast, anti-CD4+ or anti-CD8+ antibody treatments partially reduced the OAD histopathology and combined anti-CD4/CD8 antibody treatment further abrogated the histopathology of the disease.
CONCLUSION: These results show that both CD4+ and CD8+ T cells have a role in the pathogenesis of OAD and that natural killer cells and alloantibodies are not necessary for the development of this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352880     DOI: 10.1097/00007890-200209150-00010

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

Review 1.  Molecular mechanisms of chronic rejection following transplantation.

Authors:  Elbert Kuo; Takahiro Maruyama; Felix Fernandez; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Human and murine obliterative bronchiolitis in transplant.

Authors:  John F McDyer
Journal:  Proc Am Thorac Soc       Date:  2007-01

3.  CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants.

Authors:  Andrew E Gelman; Mikio Okazaki; Jiaming Lai; Christopher G Kornfeld; Friederike H Kreisel; Steven B Richardson; Seiichiro Sugimoto; Jeremy R Tietjens; G Alexander Patterson; Alexander S Krupnick; Daniel Kreisel
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

4.  Short-course rapamycin treatment preserves airway epithelium and protects against bronchiolitis obliterans.

Authors:  Jacob R Gillen; Yunge Zhao; David A Harris; Damien J LaPar; Irving L Kron; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2013-06-24       Impact factor: 4.330

5.  Detection of lung transplant rejection in a rat model using hyperpolarized [1-13 C] pyruvate-based metabolic imaging.

Authors:  Sarmad Siddiqui; Andreas Habertheuer; Yi Xin; Mehrdad Pourfathi; Jian-Qin Tao; Hooman Hamedani; Stephen Kadlecek; Ian Duncan; Prashanth Vallabhajosyula; Ali Naji; Shampa Chatterjee; Rahim Rizi
Journal:  NMR Biomed       Date:  2019-05-21       Impact factor: 4.044

6.  Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation.

Authors:  Takashi Ohtsuka; Paul S Changelian; Diane Bouïs; Kathleen Noon; Hiroaki Harada; Vibha N Lama; David J Pinsky
Journal:  J Immunol       Date:  2010-06-14       Impact factor: 5.422

7.  CD154 deficiency uncouples allograft CD8+ T-cell effector function from proliferation and inhibits murine airway obliteration.

Authors:  P D Shah; E E West; A B Whitlock; J B Orens; J F McDyer
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

Review 8.  Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.

Authors:  Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

9.  Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.

Authors:  Lamis Jarvinen; Linda Badri; Scott Wettlaufer; Takashi Ohtsuka; Theodore J Standiford; Galen B Toews; David J Pinsky; Marc Peters-Golden; Vibha N Lama
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  Bronchiolitis obliterans induced by intratracheal papaverine: a novel animal model.

Authors:  J Svetlecic; A Molteni; B Herndon
Journal:  Lung       Date:  2004       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.